Article: Helicos's RNA mapping called a step forward ; Cambridge firm's method could help control diseases

NEW YORK - Scientists at Cambridge-based firm Helicos BioScience Corp. have mapped RNA, or ribonucleic acid - a key player in each person's genetic blueprint - in a step that might boost researchers' search for the roots of disease.

The technique for showing the sequence of RNA is more accurate than a previous method, which required the RNA sample to be converted to its cousin DNA before it could be measured, according to a report in the journal Nature yesterday.

The technology will be commercially available as soon as next year and could benefit companies building new RNA-based drugs.

Being able to identify RNA directly will uncover corresponding areas of DNA, previously called "junk," ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!